Abstract:The human mitochondrial 12S ribosomal RNA (rRNA) A1555G mutation has been associated with aminoglycoside-induced and nonsyndromic deafness in many families worldwide. Our previous investigation revealed that the A1555G mutation is a primary factor underlying the development of deafness but is not sufficient to produce a deafness phenotype. However, it has been proposed that nuclear-modifier genes modulate the phenotypic manifestation of the A1555G mutation. Here, we identified the nuclear-modifier gene TRMU, which encodes a highly conserved mitochondrial protein related to transfer RNA (tRNA) modification. Genotyping analysis of TRMU in 613 subjects from 1 Arab-Israeli kindred, 210 European (Italian pedigrees and Spanish pedigrees) families, and 31 Chinese pedigrees carrying the A1555G or the C1494T mutation revealed a missense mutation (G28T) altering an invariant amino acid residue (A10S) in the evolutionarily conserved N-terminal region of the TRMU protein. Interestingly, all 18 Arab-Israeli/Italian-Spanish matrilineal relatives carrying both the TRMU A10S and 12S rRNA A1555G mutations exhibited prelingual profound deafness. Functional analysis showed that this mutation did not affect importation of TRMU precursors into mitochondria. However, the homozygous A10S mutation leads to a marked failure in mitochondrial tRNA metabolisms, specifically reducing the steady-state levels of mitochondrial tRNA. As a consequence, these defects contribute to the impairment of mitochondrial protein synthesis. Resultant biochemical defects aggravate the mitochondrial dysfunction associated with the A1555G mutation, exceeding the threshold for expressing the deafness phenotype. These findings indicate that the mutated TRMU, acting as a modifier factor, modulates the phenotypic manifestation of the deafness-associated 12S rRNA mutations.

Genomic Organization, Expression, and Subcellular Localization of Mouse Mitochondrial Seryl-Trna Synthetase.

Identification and characterization of mouse TRMU gene encoding the mitochondrial 5-methylaminomethyl-2-thiouridylate-methyltransferase.

Identification and Characterization of Mouse MTO1 Gene Related to Mitochondrial Trna Modification.

Human TRMU encoding the mitochondrial 5-methylaminomethyl-2-thiouridylate-methyltransferase is a putative nuclear modifier gene for the phenotypic expression of the deafness-associated 12S rRNA mutations.

Identification and Characterization of Mouse GTPBP3 Gene Encoding a Mitochondrial GTP-binding Protein Involved in Trna Modification

Cloning and Characterization of Mouse Mterf Encoding a Mitochondrial Transcriptional Termination Factor.

Tissue-specific Expression Atlas of Murine Mitochondrial Trnas

Mutations in MTO2 Related to Trna Modification Impair Mitochondrial Gene Expression and Protein Synthesis in the Presence of a Paromomycin Resistance Mutation in Mitochondrial 15 S Rrna

Isolation and Characterization of the Putative Nuclear Modifier Gene MTO1 Involved in the Pathogenesis of Deafness-associated Mitochondrial 12 S rRNA A1555G Mutation

A Human Mitochondrial Gtp Binding Protein Related to Trna Modification May Modulate Phenotypic Expression of the Deafness-Associated Mitochondrial 12s Rrna Mutation

The Processing of Human Mitochondrial Leucyl-Trna Synthetase in the Insect Cells

Subcellular Localization and RNA Interference of an RNA Methyltransferase Gene from Silkworm, Bombyx Mori

Human mitochondrial leucyl-tRNA synthetase with high activity produced from Escherichia coli.

Mutation in Trmu Related to Transfer Rna Modification Modulates the Phenotypic Expression of the Deafness-Associated Mitochondrial 12s Ribosomal Rna Mutations

Structural basis for shape-selective recognition and aminoacylation of a D-armless human mitochondrial tRNA

The G3-U70-independent tRNA recognition by human mitochondrial alanyl-tRNA synthetase.

Selective Degradation of Trnaser(agy) is the Primary Driver for Mitochondrial Seryl-Trna Synthetase-Related Disease.

Localization and RNA Binding of Mitochondrial Aminoacyl tRNA Synthetases

Three human aminoacyl-tRNA synthetases have distinct sub-mitochondrial localizations that are unaffected by disease-associated mutations.

CMTR-1 RNA methyltransferase mutations activate widespread expression of a dopaminergic neuron-specific mitochondrial complex I gene

Expression, Purification and Oligomerization of the S-adenosylmethionine Transporter.